%0 Journal Article %T Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry %A Andreas D. Hartkopf %A Andreas Schneeweiss %A Bernhard Volz %A Carsten Hielscher %A Christian Kurbacher %A Christoph Thomssen %A Diana L¨¹ftner %A Diethelm Wallwiener %A Erik Belleville %A Florin-Andrei Taran %A Friedrich Overkamp %A Hans Tesch %A Hans-Christian Kolberg %A Jens Huober %A Johannes Ettl %A Lothar H£¿berle %A Markus Wallwiener %A Matthias Geberth %A Matthias W. Beckmann %A Michael P. Lux %A Michael Untch %A Naiba Nabieva %A Pauline Wimberger %A Peter A. Fasching %A Peyman Hadji %A Rachel Wuerstlein %A Sara Y. Brucker %A Tanja N. Fehm %A Volkmar M¨¹ller %A Wolfgang Abenhardt %A Wolfgang Janni %J Archive of "Cancers". %D 2019 %R 10.3390/cancers11010010 %K advanced breast cancer %K metastatic %K chemotherapy %K antihormone therapy %K HER2 c-erbB2 %K HER2/neu %K trastuzumab %K pertuzumab %K T-DM1 %K lapatinib %U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357172/